Clinical Trial

TECAR Therapy on Pain and Quality of Life in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 7, 2026 (before its estimated April 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Evaluate the effect of TECAR therapy on pain, voiding, erectile function, sleep quality and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome.
Trial Details
NCT Number NCT07324239
Lead Sponsor Middle East University
Conditions Prostatitis
Enrollment 60 participants
Start Date 2026-01-02
Primary Completion 2026-04-01 (estimated)
Study Completion 2026-04-07 (estimated)
Updated on ClinicalTrials.gov 2026-01-07